Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model

Transplantation. 2021 Sep 1;105(9):1944-1956. doi: 10.1097/TP.0000000000003598.

Abstract

For many individuals with end-stage liver disease, the only treatment option is liver transplantation. However, liver transplant rejection is observed in 24%-80% of transplant patients and lifelong drug regimens that follow the transplant procedure lead to serious side effects. Furthermore, the pool of donor livers available for transplantation is far less than the demand. Well-characterized and physiologically relevant models of liver transplantation are crucial to a deeper understanding of the cellular processes governing the outcomes of liver transplantation and serve as a platform for testing new therapeutic strategies to enhance graft acceptance. Such a model has been found in the rat transplant model, which has an advantageous size for surgical procedures, similar postoperative immunological progression, and high genome match to the human liver. From rat liver transplant studies published in the last 5 years, it is clear that the rat model serves as a strong platform to elucidate transplant immunological mechanisms. Using the model, we have begun to uncover potential players and possible therapeutic targets to restore liver tolerance and preserve host immunocompetence. Here, we present an overview of recent literature for rat liver transplant models, with an aim to highlight the value of the models and to provide future perspectives on how these models could be further characterized to enhance the overall value of rat models to the field of liver transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomedical Research*
  • Cytokines / metabolism
  • Graft Rejection / immunology
  • Graft Rejection / metabolism
  • Graft Rejection / prevention & control*
  • Graft Survival*
  • Humans
  • Immune Checkpoint Proteins / metabolism
  • Immunocompromised Host
  • Immunosuppressive Agents / pharmacology*
  • Immunosuppressive Agents / toxicity
  • Liver Transplantation* / adverse effects
  • Models, Animal
  • Rats
  • Signal Transduction
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • Transplantation Tolerance*

Substances

  • Cytokines
  • Immune Checkpoint Proteins
  • Immunosuppressive Agents